DOC2 (Double C2 domain) antibodies are essential tools for studying the DOC2 protein family, which includes two isoforms, DOC2A and DOC2B. These calcium-binding proteins are characterized by tandem C2 domains and play critical roles in calcium-dependent membrane trafficking and neurotransmitter release. DOC2 isoforms are implicated in synaptic vesicle exocytosis, acting as calcium sensors that interact with SNARE complexes and other regulators like Munc13-1. DOC2A is predominantly expressed in the brain, while DOC2B shows broader tissue distribution, including endocrine cells.
Antibodies targeting DOC2 are used to investigate its localization, expression levels, and interactions in neuronal and secretory systems. They enable detection in techniques like Western blotting, immunohistochemistry, and immunofluorescence. Research using DOC2 antibodies has linked the protein to synaptic plasticity, learning, and memory, with dysregulation observed in neurological disorders such as epilepsy, Alzheimer’s disease, and schizophrenia.
The development of isoform-specific DOC2 antibodies has been crucial for distinguishing the unique functions of DOC2A and DOC2B, particularly in calcium-triggered processes. These antibodies also aid in exploring DOC2’s non-neuronal roles, including hormone secretion and cancer progression, where abnormal DOC2 expression may influence cell signaling or metastasis. Overall, DOC2 antibodies remain vital for unraveling the protein’s diverse physiological and pathological mechanisms.